Biology on your terms. develope organisms using computer automation501-1000 Employees
- B2B
- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
- 4.6Highly ratedGinkgo Bioworks is highly rated on Glassdoor, with 4.6 out of 5 stars
- 4.5Strong LeadershipEmployees rate Ginkgo Bioworks 4.5/5 on Glassdoor for faith in leadership
Ginkgo Bioworks Funding
$799.1M
88 rounds
Y Combinator
Ginkgo Bioworks is active in the following markets / industries: biotechnology, life sciences, health care, medical, chemicals, alternative medicine, bio pharm and nutrition. The company has secured funding across 8 rounds, totaling in an amount of $799.1M. Their most recent funding was raised on May 28, 2020.
Funding Rounds
F
$70000000E
$290000000Series ESep 2019
D
$275000000C
$100000000C
$10000000B
$45000000
A
$9000000
S
$120000Investors of Ginkgo Bioworks
-Principal at Javelin Venture Partners
-Early finance employee at Uber
Guillaume Demers
Web entrepreneur, investor, crypto enthusiast and dad.
Co-founder of Atrium LTS and @Whale. Founded @Exec and @Justin.tv. Partner at Y Combinator.
CEO at @XTX Markets
Snapchat Security Engineering
Baillie Gifford
Rounds
C
Viking Global Investors
Global investment firm managing capital across public equity, private equity, and credit strategies
Rounds
C
C
B
Cascade Investment
Rounds
C
C
Allen & Company
Rounds
C